All posts by imreal

doForms Releases Automatic Mobile Form That Screens Employee Health Amid COVID-19 Outbreak


With doForms, we were able to rapidly design and deploy a mobile screening tool that all of our field staff can utilize on a daily basis so that we can gain instant insight into their health status and work availability to protect the health of our patients! – Dr. Robert Rosati

doForms – a mobile forms solutions provider that enables real-time data collection and custom mobile forms for small businesses, mid-sized organizations and enterprises – recently released an automatic mobile form that conducts employee wellness checks each morning.

By gathering real-time data about employees’ current health, businesses can more accurately assess potentially contagious persons. This enables them to build a work schedule aimed at completing essential tasks while limiting COVID-19 exposure for clients. The form was designed in collaboration with Visiting Nurse Association (VNA) Health Group, a 108-year old home health, hospice and community-based care organization headquartered in Holmdel, New Jersey.

This form is currently used by healthcare providers, although it can be utilized by any industry and essential business that requires person-to-person interactions.

VNA Health Group, with operations in New Jersey, mid-central Ohio, and southeast Florida, relies on this new mobile form to understand whether clinicians have any signs, symptoms or possible exposure to coronavirus. This allows them to establish if team members need to be tested for COVID-19 and increases their ability to send healthy, non-contagious employees into the field.

“With doForms, we were able to rapidly design and deploy a mobile screening tool that all of our field staff can utilize on a daily basis so that we can gain instant insight into their health status and work availability to protect the health of our patients,” says Dr. Robert Rosati, vice president of quality and research at VNA Health Group. “The doForms platform is an ideal solution to quickly design and implement a critical mobile application without significant development time. It was done in a few hours and we were receiving real-time health information from our employees instantly!”

The COVID-19 Screening Tool asks employees several questions regarding their current health status, including if any signs or symptoms of headache, cough, fever, sore throat, loss of taste or smell or other reported COVID-19 symptoms are present.

The form also asks if the employee has been able to avoid large gatherings or if they had any contact with someone diagnosed with COVID-19. This daily, real-time reporting has allowed VNAHG to monitor the health of over 1,000 employees in real-time.

Learn more about doForms’ features that support workforces throughout the COVID-19 outbreak HERE.

About VNA Health Group

Visiting Nurse Association (VNA) Health Group is the largest independent, nonprofit provider of home-based health services in New Jersey, Mid-Central Ohio and southeast Florida. Founded over 108 years ago with a mission to care for the community, today VNA Health Group helps individuals and families achieve their best level of health and well-being by providing high quality, compassionate home health, hospice, palliative and community-based care and offers private-pay personal care services. A full range of primary care services are available through the VNACJ Community Health Centers. Currently, VNA Health Group employs nearly 2,500 people and cares for over 160,000 individuals and families annually with a special focus on vulnerable populations such as children, older adults and those with serious and disabling chronic illnesses. Our unique partnership model with health systems leverages our clinical and technical resources to operate VNA of Central Jersey Home Care and Hospice, Robert Wood Johnson Visiting Nurses, VNA of Englewood, Barnabas Health Home Care and Hospice, Cleveland Clinic Florida Visiting Nurses, Visiting Physician Services, and Visiting Nurse Association of Ohio. For more information about VNA Health Group and the VNAHG Foundation please call 800.862.3330, visit http://www.vnahg.org and follow us on Twitter at http://twitter.com/VNAHealthGroup or @VNAHealthGroup.

Please support the VNA COVID-19 Emergency Response Fund TODAY. Your gift will make a vital difference for our dedicated frontline doctors, nurses and clinicians caring for patients in their homes and the community in the fight against COVID-19.

Share article on social media or email:



RealINSIGHT Offers Two Months of Free Access for Commercial Real Estate Lenders During COVID-19 Crisis


RealInsight logo

There is no better time to leverage technology to help manage your CRE portfolio.

The right technology and cloud-based tools are essential for every company during these turbulent times. To support the CRE industry, RealINSIGHT is offering new prospects two months of free access to its leading software solution for CRE professionals.

Onboarding and U.S.-based support are included during the free 60-day access period for those interested in managing a sample of their portfolio.

“There is no better time to leverage technology to help manage your portfolio,” says James Shevlin, President & COO. “Understanding portfolio exposure to the COVID-19 outbreak in real time will allow CRE professionals to keep ahead of the situation, positioning themselves for long-term success.”

CRE professionals can work from anywhere with the following RealINSIGHT features:

Document Management & File Sharing

Secure and organized online access to documents is critical. Documents need to be made available to the right people – and only the right people. That’s where user specific permissions make it easy to allow document-by-document access to authorized users.

Real-Time Alerts & Collaboration

Remote work compounds the need for rapid collaboration. Users need to easily communicate, keeping everyone engaged as if they were in the office.

Automated Data Integration

Siloed information is an issue at the best of times and in a remote work situation can prove problematic. Seamless integrations with legacy systems and a direct Covid-19 FEMA feed allows you to manage risk in real time.

Custom Dashboards

Well-structured and intuitive dashboards are critical to CRE surveillance and asset management. RealINSIGHT puts critical business information on a single screen, dramatically improving accessibility for faster and more informed decision making.

About RealINSIGHT

RealINSIGHT, a software solution built by industry experts, is the only choice that commercial real estate lenders, investors, and servicers value and trust. Implemented by some of the most active lenders and largest financial service firms in the world – including its affiliate company CWCapital – RealINSIGHT provides CRE professionals with a modern cloud-based platform designed to streamline workflows and effectively manage all aspects of their debt investments. RealINSIGHT is headquartered in Bethesda, Maryland, with offices in Dallas, Texas, and New York. To learn more, visit the company at RealINSIGHT.com or follow RealINSIGHT on LinkedIn.

Share article on social media or email:

Solutions in Business, Health, and Education featured on this Week’s LIVE Stream Episode of Worldwide Business with kathy ireland®


Worldwide Business with kathy ireland® Streaming LIVE Sun. 4/26 and Weds. 4/29

Worldwide Business with kathy ireland® is excited to announce that they will be LIVE streaming this week’s episode of their successful business program on Sunday, April 26, 2020 and Wednesday, April 29, 2020 at 8:00pm ET / PT

Worldwide Business with kathy ireland® is excited to announce that they will be LIVE streaming this week’s episode of their successful business program on Sunday, April 26, 2020 and Wednesday, April 29, 2020 at 8:00pm ET / PT for ease of viewing and sharing! This episode’s exclusive interviews will spotlight key executives from Blue Eagle Consulting, FLUIDDA, AnswerConnect, and Regent University.

As leaders in their industries, the four companies featured demonstrate the unique branding opportunity Worldwide Business with kathy ireland® offers by bringing strategic messages and unique solutions to the business community.

Company Spotlight

Blue Eagle Consulting: Headquartered in Birmingham, Alabama, and with a network of seasoned information systems professionals, Blue Eagle Consulting provides healthcare organizations with the people they need to ensure their large software investments perform as expected. Blue Eagle Consulting consultants are those in the top ten percent in their field, with 10 to 20 years in the field and/or five to seven years of qualified experience.

President, Mark Griffin states that Blue Eagle Consulting stands out from other consulting services for many reasons; one of which is their quick turnarounds. He explains, “We have the proven ability to deliver. On average, it only takes us about seven to ten business days from the time we have a conversation with a client until we’ve paired a consultant or group of consultants for the needs they have.”

FLUIDDA: Headquartered in Belgium, FLUIDDA is leading the field of functional respiratory imaging (FRI) with their company’s technique which combines HRCT scans and computational fluid dynamics technology. In a world where the quality of air is under stress, and with one person dying from a respiratory condition every minute, patients with pulmonary diseases deserve better, faster, less costly treatments. FLUIDDA’s mission is to optimize treatment pathways, reduce healthcare costs and limit the go-to-market time of respiratory drugs, pulmonology medical devices and therapies.

CEO, Dr. Jan DeBacker says that they are actually able to help people with COVID-19. He explains, “This virus binds in the lungs to the receptors. The body tries to fight the virus by creating an inflammatory response… In the early stages, FLUIDDA can detect how much the lungs are already compensating for this disease and predict whether a patient will stay stable or if the patient is at risk of ending up in the ICU.”

AnswerConnect: Headquartered in Portland, Oregon, and serving clients around the world since 1994, AnswerConnect delivers exceptional customer care and has continuously adapted to the changing landscape of business and communication. From 24/7 answering services to industry-specific contact center solutions, the company’s ever-increasing portfolio of service offerings for early start-ups to multinational organizations has helped them grow consistently year after year.

CEO, Natalie Ruiz explains that AnswerConnect provides unique tools and services for virtual workers – a need that many companies are newly experiencing right now. She states, “At our core, we provide virtual reception and answering services, making sure that phone calls are answered 24/7/365 for our businesses… they can stay connected to their teams, whether they’re out in the field, at their office, or at their home office.”

Regent University: Founded in 1978, Regent University’s 11,000 students study on either its 70-acre campus in Virginia Beach, VA., or online around the world. The university offers associate’s, bachelor’s, master’s and doctoral degrees from a Christian perspective in more than 135 program areas. To encourage social distancing and to help ease financial struggles associated with COVID-19, Regent University is now offering a “social distancing scholarship” to all new students who are pursuing their bachelor’s, master’s or doctoral degree online with Regent.

Vice President of Academic Affairs, Dr. Gerson Moreno-Riano shares that Regent University always strives to serve its students, and that COVID-19 and the uncertainty surrounding the virus will not slow that down. He says, “Our social distancing scholarship gives students the opportunity to begin their program here at Regent to prepare for the future economy and future market.”

To learn more about the companies above, click here on Sunday, April 26, 2020 and Wednesday, April 29, 2020 at 8:00pm ET / PT to watch the LIVE stream of this week’s episode of Worldwide Business with kathy ireland®!

About Worldwide Business with kathy ireland®

Worldwide Business with kathy ireland® is a weekly half-hour show featuring global executives sharing their business insights and framing the opportunities shaping their industries. Hosted by a business mogul, Kathy Ireland interviews some of the brightest minds in business today. The show broadcasts on Fox Business Network as part of their sponsored content line up and globally on Bloomberg Television. Worldwide Business with kathy ireland® extends beyond the weekly on-air program with digital content delivered on various video platforms and across social media.

Share article on social media or email:

Entertainment Charity Initiative Cast4Good Launches Fan-Centric Tech Platform To Benefit Feeding America® COVID-19 Relief Fund


News Image

We are thrilled with the success of Tuesday night’s launch event with the cast of ‘Roswell, New Mexico.’ We could not have picked a better cast to join us in supporting Feeding America. We’re already hard at work planning future Cast4Good online chats to benefit other worthy causes.

Cast4Good was founded by Todd Krim, President & CEO of The Krim Group, as a creative new fundraising initiative in response to the ongoing global COVID-19 crisis, but will soon be expanded to support a wide range of charities and causes including climate change, humanitarian relief, social justice reform and gender equality. With the advent of social distancing and so many individuals turning towards entertainment for comfort and solace, Cast4Good unites cast members from beloved television series and films for exclusive one-hour moderated discussions and fan Q&As that audiences globally can watch and participate in from the comfort of their own homes – all while raising funds for charity and fostering a sense of community during these unprecedented times. Proceeds raised from the ticket sales are donated to the charity organization being highlighted.

The debut Cast4Good event took place on Tuesday, April 21st with the cast of The CW’s “Roswell, New Mexico,” as well as the creator and producer Carina Adly MacKenzie. Immediately following the panel, fans had the opportunity to have 1-on-1 video chats with select cast members via the digital platform, Looped. Proceeds raised from this inaugural event are being donated to Feeding America® and their COVID-19 Response Fund, a national food-and-fundraising effort to support people facing hunger and local food banks who help them.

“We are so thrilled with the success of last night’s launch event with the cast of ‘Roswell, New Mexico.’ We could not have picked a better cast to join us in our ‘give back’ efforts and the fan engagement was through the roof. We’re already hard at work planning future ‘cast chats’ to benefit other worthy causes,” said Cast4Good founder Todd Krim.

For media distribution, please find the following link to access a highlight reel from the launch event.

For more information on Cast4Good and to join the online community, please visit http://www.Cast4Good.com.

ABOUT TODD KRIM AND THE KRIM GROUP:

A lawyer-turned-charity matchmaker, Todd Krim, left his successful law practice to pursue a higher calling. Over the past decade Todd, known in Hollywood circles as “Mr. Charity,” has become the entertainment industry’s go-to person for charities looking to connect with celebrities and vice versa. He’s fostered partnerships between countless nonprofits and celebrities, advised for-profit companies on social impact campaigns, and produced widely publicized charity events including Richard Branson’s Venezuela Aid Live benefit in Colombia and the United Nations’ “Play It Out” Music Festival in Antigua. He has been featured in major magazines and media outlets including Variety, The Hollywood Reporter, USA Today, The New York Times, The Chronicle of Philanthropy, Real Leaders Magazine and Global Citizen Magazine. His most recent project, the “World Is In Our Hands” social media campaign he launched with director/photographer Justin Wu, supports the UN Environment Programme’s ActNow campaign and features Antonio Banderas, Joaquin Phoenix, Susan Sarandon, Rainn Wilson, Evan Peters, Maggie Q and Rosario Dawson, to name a few. Visit http://www.TheKrimGroup.com.

ABOUT FEEDING AMERICA®:

Feeding America® is the largest hunger-relief organization in the United States. Through a network of 200 food banks and 60,000 food pantries and meal programs, we provide meals to more than 40 million people each year. Feeding America also supports programs that prevent food waste and improve food security among the people we serve; educates the public about the problem of hunger; and advocates for legislation that protects people from going hungry. Individuals, charities, businesses and government all have a role in ending hunger. Donate. Volunteer. Advocate. Educate. Together we can solve hunger. Visit http://www.FeedingAmerica.org.

ABOUT LOOPED:

Looped is a platform where fans connect virtually with their favorite talent – anytime and anywhere in the world. Talent can go live for their fans, and even upgrade fans to VIP for access to a virtual meet & greet. Visit http://www.LoopedLive.com.

ABOUT ROSWELL, NEW MEXICO:

Roswell, New Mexico is from Warner Bros. Television and CBS Television Studios, in association with Amblin Television and Bender Brown Productions, with executive producers Carina Adly MacKenzie (The Originals), Christopher Hollier (Once Upon a Time), Julie Plec (The Vampire Diaries), Darryl Frank and Justin Falvey (The Americans), Lawrence Bender (Pulp Fiction) and Kevin Kelly Brown (Roswell). Roswell, New Mexico airs on The CW on Mondays at 9:00PM.

CAST4GOOD:

Website: http://www.Cast4Good.com

Instagram: @Cast4Good

Twitter: @Cast4Good

Facebook: @Cast4Good

Official Hashtag: #Cast4Good

MEDIA CONTACTS:

Jessica Sze

Shelter PR

E-mail: JessicaS@shelterpr.com

Molly Stead

Shelter PR

E-mail: MollyS@shelterpr.com

Share article on social media or email:

CV19 Lab Testing Dashboard Powered by hc1 is Fastest to Identify Emerging Local Spread and Control of COVID-19


hc1 announced a powerful Local Risk Index (LRI) now available within cv19dashboard.org.

“The Local Risk Index highlights hot spots where the virus is accelerating in a dramatic way.”

Today, hc1 announced a powerful Local Risk Index (LRI) now available within cv19dashboard.org that delivers at-a-glance analysis of accelerating or decelerating COVID-19 infection rates by county and Public Use Microdata Area (PUMA).

“Healthcare planners will be alerted to where and when action must occur,” said Peter Plantes, M.D., hc1 Physician Executive. “Based on the known average clinical course of COVID-19 (from incubation to potential ICU-transfer and ventilation), timely, local data visualization enables users to predict 5 to 21 days in advance an acceleration of patient volumes with symptomatic COVID-19, and the associated increase in local demand for COVID-19 care resources like ER visits, hospitalizations, and ICU transfers.”

A clinical advisory team of epidemiological and healthcare experts advised hc1 in developing the LRI. “The Local Risk Index highlights hot spots where the virus is accelerating in a dramatic way. And if the LRI is falling then the virus spread is decelerating within the selected population area. Public health officials and hospitals can respond accordingly to these realtime objective measurements from the community,” said Richard Olds, MD, MCAP, International Expert – Infectious Diseases, Former U.S. Medical School Dean. “Think of it like a pollen count. If your local county has a high pollen score, then you’re more likely to develop active allergy symptoms.”

Anonymized trending data from a coalition of more than 20,000 lab testing locations supports the COVID-19 Lab Testing Dashboard’s Local Risk Index, as well as visualizations of COVID-19 testing rates, positive and negative test results, and key demographic filters like age and gender down to the county and sub-county (Public Use Microdata Area) level. Approximately 40 percent of the national COVID-19 lab testing results are reflected in the dashboard’s insights.

“Partners across the country have told us health systems and public health officials need more timely and granular insight to better plan for and address the needs of the CV-19 pandemic,” said Brad Bostic, hc1 CEO. “hc1’s core business focuses on transforming lab data into personalized healthcare insights. Given our unique assets and capabilities, we mobilized our team and lab coalition partners to quickly deliver a critical component of national surveillance infrastructure that addresses these challenges.”

The CV19 Lab Testing Dashboard powered by hc1 is a free public health service for individuals directly involved with implementing policies and delivering care to mitigate the spread of COVID-19. Included are public health officials, government agencies, and healthcare providers. Qualified individuals need only request access at cv19dashboard.org.

All trends in the dashboard are based on de-identified, aggregated data in accordance with the Health Insurance Portability and Accountability Act (HIPAA) privacy requirements. Accredited COVID-19 testing labs are encouraged to learn more and support this important public health initiative by visiting cv19dashboard.org/join.html.

About hc1®

Founded to improve lives with high-value care, hc1 has emerged as the leader in bioinformatics for precision testing and prescribing. The cloud-based hc1 High-Value Care Platform® organizes volumes of live data, including lab results, genomics, and medications, to deliver solutions that ensure that the right patient gets the right test and the right prescription. Today, the hc1 Platform powers solutions that optimize diagnostic testing and prescribing for millions of patients nationally. To learn more about hc1’s proven approach to personalizing care while eliminating waste for thousands of health systems, diagnostic laboratories, and health plans, visit http://www.hc1.com and follow us on Twitter, Facebook, and LinkedIn.

Share article on social media or email:



Omnipresence Launches CXMnow.io for Life Sciences in the Microsoft Azure Marketplace


Indegene Omnipresence

Indegene Omnipresence, Inc. announced the launch of CXMnow.io in the Azure Marketplace today, an online store providing applications and services for use on Microsoft Azure. The customer experience management (CXM) technology allows life sciences organizations with certain well-defined business needs to sign up online for a built-for-purpose customer engagement capability to use in their commercial or medical operations.

Sajan Parihar, Senior Director, Microsoft Azure Platform at Microsoft Corp, said “We’re pleased to welcome the Omnipresence Life Sciences CXM to the Microsoft Azure Marketplace, which gives our partners great exposure to cloud customers around the globe. Azure Marketplace offers world-class quality experiences from global trusted partners with solutions tested to work seamlessly with Azure.”

Avoiding the lengthy procurement, implementation, and customization needs typical of platforms from traditional providers of CRMs, marketing automation, contact center, medical case management, event management, and the like within this regulated industry, CXMnow.io comes equipped to meet most life sciences needs and can be used almost immediately after the online sign-up. It also places the life sciences customers, including healthcare practitioners, business partners such as pharmacies and hospital administrators, and other stakeholders, as the central focus, enabling omnichannel experiences these customers have come to expect. Furthermore, CXMnow.io combines CRM, omnichannel engagement, marketing automation, event management, advanced analytics, and AI capabilities into a single platform and is available in a variety of bundles for particular use cases.

Sanjay Virmani, CEO of Indegene Omnipresence, said, “With CXMnow we are responding to the challenge many future gazing life sciences organizations face with their digital transformation initiatives, meaning a time-consuming technology selection and deployment process. Their needs are well known, industry compliancy requirements are well established, the goal of providing personalized, elevated experiences to their customers is clear, so why should they not be able to get going immediately like with many other enterprise software today.”

The Azure Marketplace is an online market for buying and selling cloud solutions certified to run on Azure. The Azure Marketplace helps connect companies seeking innovative, cloud-based solutions with partners who have developed solutions that are ready to use.

Omnipresence is a unified customer experience platform for healthcare and life sciences organizations with CRM, omnichannel engagement, advanced analytics, and AI capabilities in a single platform. The platform enables organizations to elevate and transform the experiences they can deliver to healthcare professionals, business partners, patients, and other stakeholders while modernizing disparate systems into a modern, digital ecosystem. The result of a strategic alliance between Indegene and Microsoft, Omnipresence unifies the power of Microsoft Azure and Microsoft AI together with Dynamics 365 and Power Platform business applications and Microsoft Office 365 and Teams for intelligence-driven productivity, collaboration, and customer experiences.

Share article on social media or email:

Artificial intelligence study demonstrates a 52% uplift in patient adherence indicators


“Research like this proves that AI makes a positive impact in patient’s lives. It validates the use of AI for adherence across a wide range of enterprise healthcare organizations.” commented Clifford Jones, CEO of AllazoHealth.

AllazoHealth, a company that uses artificial intelligence (AI) to help enterprise healthcare companies improve medication adherence and quality outcomes, has released a new study demonstrating the impact of AI on patient adherence indicators. The poster outlining the study was published and awarded a gold medal by the Academy of Managed Care Pharmacy (AMCP). It shows that AI can effectively select which patients will achieve greater uplifts in refill rates by adding a pharmacy-based intervention to a call center intervention.

“Our team was pleased to be awarded a gold ribbon by AMCP, based on our abstract on how AI can uplift adherence indicators,” commented Clifford Jones, CEO of AllazoHealth. “Research like this proves that AI makes a positive impact in patient’s lives. It validates the use of AI for adherence across a wide range of enterprise healthcare organizations.”

The poster outlines a study showing the effectiveness of using AI to target high-risk patients who would benefit the most from receiving pharmacy-based interventions in addition to call center interventions. Providing a dual intervention approach, both call center-based and pharmacy-based, is more expensive than just utilizing a call center. Therefore, cost efficiency can be improved by reserving the dual intervention approach for patients where it will provide greater uplift in adherence.

High-risk patients who had a prescription fill due or past-due were selected for medication adherence interventions by the AI. Patients who were predicted to benefit from dual interventions, and then received the interventions, were 52% more likely to refill their prescriptions within 14 days than other groups.

The full poster is available for download at

https://allazohealth.com/wp-content/uploads/AllazoHealth-AMCP-Poster.pdf

About AllazoHealth

AllazoHealth uses artificial intelligence to make a positive impact on individual patient behavior. We optimize medication adherence and quality outcomes for pharmaceutical companies, payers, and pharmacies. Our AI engine targets individual patients with the right intervention, the right content, at the right time.

Share article on social media or email:

Earl R. Fender Joins as President & CEO


News Image

We are very excited to welcome Earl Fender to the Nalu team. I cannot think of a stronger person to lead Nalu as it enters its full commercialization and growth phase than Earl. He brings over 30 years of successful experience in building and leading medical technology companies.

Nalu Medical, Inc. (“Nalu”), a global medical device company that provides miniaturized, battery-free implantable solutions for the treatment of chronic pain in Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS), announced today that Earl R. Fender has been appointed President and Chief Executive Officer and member of the Board of Directors. Mr. Fender succeeds Keegan Harper, who has stepped down as CEO but will remain as Chairman of the Board.

“We are very excited to welcome Earl Fender to the Nalu team,” said Mr. Harper. “I cannot think of a stronger person to lead Nalu as it enters its full commercialization and growth phase than Earl. He brings over 30 years of successful experience in building and leading medical technology companies. For the last 12-years, he worked in the chronic pain space as the CEO of Vertiflex, Inc., which was acquired by Boston Scientific in June 2019. He brings a wealth of experience in building industry-leading, high growth companies and I am excited to have him join the Nalu team.”

“I am very excited and proud to join Nalu’s illustrious team who has developed such differentiated technology to positively impact the lives of patients in the U.S. and abroad,” said Mr. Fender. “The uniquely miniaturized, battery-free and easily upgradable Nalu implantable pulse generator system will help expand patient acceptance in both spinal cord and peripheral nerve stimulation.”

Mr. Fender added, “The Board thanks Keegan for his years of dedicated service to Nalu since founding the Company in 2014. As Nalu’s co-founder and CEO, Keegan built a strong team, developed a sophisticated product in record time, launched a successful first in human study in Australia, received FDA clearance in SCS and PNS, received CE mark approval, and completed a successful limited clinical launch in the U.S. We look forward to his continued leadership as Nalu’s Chairman.”

About the Nalu Neurostimulation System

The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The system is highly capable and easily upgradeable, providing a menu of therapy options. To learn more, please visit http://www.nalumed.com.    

About Nalu Medical

Nalu Medical, Inc. is a privately held early-stage medical device start-up company based in Carlsbad, California. The team of seasoned entrepreneurs, engineers and scientists are developing the next generation of medical devices to address a number of poorly treated clinical conditions. Nalu Medical’s vision is to modernize and enhance medical device technology to improve people’s lives.

Share article on social media or email:

SECO and IBD Partner for the Realization of Respira Non-invasive Pulmonary Ventilators


News Image

SECO, a leading company in the hi-tech sector, specializing in computer miniaturization, backed by FII Tech Growth managed by Fondo Italiano d’Investimento SGR, today announced a partnership with IBD, an innovative Italian company operating in the biomedical market, for the development of Respira, a new non-invasive pulmonary ventilator created in response to the current health emergency of the COVID-19 pandemic. Respira was developed by a team of Italian doctors with direct and extensive experience on the front lines of the pandemic.

SECO’s technological capabilities in combination with IBD’s knowledge and competencies in the medical sector, have brought Respira to life. Respira is a compact and portable high-flux, pulmonary ventilator for patients with COVID-19-related pneumonia in both domestic and hospital environments. The new ventilators, which bypass the need for invasive intubation, are equipped with touchscreen displays for easy and intuitive use.

“It gives me great pride that in such difficult times two Italian industry leaders like SECO and IBD have brought together their technological competencies to provide a tangible contribution to the healthcare system and its patients, through an innovative, non-invasive and portable solution for pulmonary ventilation,” said Massimo Mauri, Chief Executive Officer for SECO.

Established in 2014, IBD designs and develops biomedical devices with the goal of innovating on portability, user-friendliness for healthcare personnel and patients, for both domestic and hospital applications. Following the concepts of “Less is More” and Lean Startup, IBD has developed, in a timely fashion and with limited resources, extremely innovative biomedical devices,” said Dr. Corrado Ghidini, MD of IBD. “As Italy has always been a leader in the biomedical field, the partnership with SECO provides the perfect complement for the realization of an industrial plan that can contribute in relaunching Italy on a global scale.”

In addition to ventilating patients affected by COVID-19 without intubation, Respira can also be used in immunodepression cases as well as those that require oxygenation in both pre-and post-intensive care. Designed in Italy and manufactured in the USA, the new pulmonary ventilators are expected to start deliveries between late May and early June 2020.

Assisted pulmonary ventilation is considered by most to be the only effective therapy for those patients affected by COVID-19-related respiratory deficiency. The innovative ventilators developed by SECO and IBD will contribute in increasing the availability of these fundamental medical devices, currently only available in limited amounts, at very high prices and exclusively used by intubated patients in ICUs.

About SECO

SECO is an Italian group with a leading global position in the sector of embedded technology and Internet of Things (IoT). Since 1979, it has been designing and producing embedded systems – industrial computers that are integrated into a client’s machine or tool, activating its functions and permitting interaction through touch/video interfaces. SECO collaborates with a broad network of strategic suppliers in the international high-tech panorama (including Intel®, AMD, NXP, NVIDIA®, Wind, and Telenor), as well as with universities, research centers and innovative start-ups, and operates on a global scale with offices in Italy, Germany, the U.S., India and Taiwan, employing more than 380 people. The industrial sectors in which SECO products are utilized range from biomedicine to wellness, industrial automation to transportation, and it has clients that are market leaders, such as Cimbali, Esaote, Evoca, and Technogym. http://www.seco.com

About FII Tech Growth

FII Tech Growth, with a fundraising target of €150 million, is the first Italian late-stage technology investment equity fund. It is managed by Fondo Italiano d’Investimento SGR and is dedicated to invest in the growth of small and medium-sized Italian companies with high-tech business models. The fund announced its first closing in September 2017 with Cassa Depositi e Prestiti as cornerstone investor. Fondo Italiano d’Investimento SGR currently manages a total of eight investment funds, dedicated to institutional investors, for a total of about Euro 3 billion of Assets Under Management. http://www.fondoitaliano.it

IBD

IBD is a biomedical devices manufacturer company conceived in London and founded in Italy in 2014. Guided by a team with +10 years of experience in dialysis and medical device design, IBD has raised so far over € 1 million in funding by angel investors and grants. It is now facing a new round of funding. http://www.ibdbiomed.com

Share article on social media or email:

Tufts CSDD-eClinical Solutions Clinical Data Study Shows 32 Percent Increase in Trial Cycle Time Metric


“Digital transformation in the life sciences industry is powered by data,” said Raj Indupuri, CEO of eClinical Solutions. “Companies adopting formal data strategies and modern technology such as the elluminate clinical data platform are faring better.”

eClinical Solutions LLC, a leading global provider of cloud-based enterprise software and software-driven clinical data services that accelerate drug development, today announced the results of The Tufts-eClinical Solutions Data Strategies & Transformation Study. Conducted with the Tufts Center for the Study of Drug Development (Tufts CSDD), the study reveals the growing number and diversity of external clinical data sources have contributed to longer database lock cycle times, resulting in downstream delays in drug development. The study found that only a third of clinical trial sponsors currently have an established data strategy in place. Given the time-consuming and labor-intensive nature of handling more diverse data sources, the study highlights the opportunity the pharmaceutical industry has to adopt new technologies and methods for managing and analyzing data to speed the drug development process.

Since 2017, large pharmaceutical companies are seeing a 32 percent increase in the time from the last patient last visit (LPLV) to database lock cycle time metric. On average, overall cycle times have increased by six days over the last two years for life sciences companies using five or more data sources. Companies that have implemented data strategies have seen marked improvement in that same metric compared to those companies with no data strategy in place.

“Digital transformation in the life sciences industry is powered by data,” said Raj Indupuri, CEO of eClinical Solutions. “The study results demonstrate that life sciences companies adopting formal data strategies and modern technology such as the elluminate clinical data platform are faring better than those companies that do not have these capabilities in place.”

“The results of this study show that sponsor companies are in transition with regards to managing rapid growth in the volume and diversity of scientific and operating data,” said Ken Getz, Deputy Director and Professor at Tufts CSDD. “All organizations are adjusting and adapting to better leverage this data with larger companies generally farther along in implementing data strategies, new mechanisms and infrastructure.”

For more on the key findings from The Tufts-eClinical Solutions Data Strategies & Transformation Study:

see Beth Harper, Senior Consultant, Tufts CSDD, discuss study highlights, read a copy of the Tufts CSDD’s March/April Impact Report: Analysis & Insight into Critical Drug Development Issues here or watch the webinar with key data presented by Ken Getz.

About eClinical Solutions LLC

eClinical Solutions is a leading global provider of cloud-based enterprise software and software-driven clinical data services. The elluminate platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies. For more information, visit http://www.eclinicalsol.com.

Share article on social media or email: